Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections

Pediatrics

Volumn 121, Issue 6, 2008, Pages 1198-1205

  Singer, Harvey S ^a,b   Gause, Colin ^a   Morris, Christina ^a   Lopez, Pablo ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Antineuronal antibodies; Cytokines; Longitudinal analysis; Lysoganglioside GM1; PANDAS

Indexed keywords

CYTOKINE; BIOLOGICAL MARKER;

ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MENTAL DISEASE; METHODOLOGY; NEUROLOGIC DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; STREPTOCOCCUS INFECTION; WESTERN BLOTTING; BLOOD; HOSPITALIZATION; IMMUNOLOGY; MICROBIOLOGY;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STREPTOCOCCAL INFECTIONS;

EID: 48949096271     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-2658     Document Type: Article

References (35)

1. Snider LA, Swedo SE. Post-streptococcal autoimmune disorders of the central nervous system. Curr Opin Neurol. 2003; 16(3):359-365
2. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264-271
3. Kurlan R. Tourette's syndrome and 'PANDAS': will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Neurology. 1998;50(6):1530 -1534
4. Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics. 2004;113(4):883-886
5. Kurlan R. The PANDAS hypothesis: losing its bite? Mov Disord. 2004;19(4):371-374
6. Singer HS, Loiselle C. PANDAS: a commentary. J Psychosom Res. 2003;55(1):31-39
7. Pavone P, Parano E, Rizzo R, Trifiletti RR. Autoimmune neu-ropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants. J Child Neurol. 2006;21(9):727-736
8. Harris K, Singer HS. Tic disorders: neural circuits, neurochem-istry, and neuroimmunology. J Child Neurol. 2006;21(8):678-689
9. Church AJ, Dale RC, Giovannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders? Arch Dis Child. 2004;89(7):611-614
10. Pavone P, Bianchini R, Parano E, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol. 2004;30(2):107-110
11. Singer HS, Loiselle CR, Lee O, Minzer K, Swedo S, Grus FH. Anti-basal ganglia antibodies in PANDAS. Mov Disord. 2004; 19(4):406-415
12. Singer HS, Hong JJ, Yoon DY, Williams PN. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology. 2005;65(11):1701-1707
13. Dale R, Candler P, Church AR, Pocock JG. Glycolytic enzymes on neuronal membranes are candidate auto-antigens in post- streptococcal neuropsychiatric disorders. Mov Disord. 2004; 19(suppl 9):S33.
14. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9(7):914-920
15. Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol. 2006;179(1-2):173-179
16. Kirvan CA, Swedo SE, Kurahara D, Cunningham MW. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity. 2006; 39(1):21-29
17. Church AJ, Dale RC, Cardoso F, et al. CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome? J Neuroimmunol. 2003;136(1-2):149-153
18. Leckman JF, Katsovich L, Kawikova I, et al. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry. 2005;57(6):667-673
19. Yoon DY, Gause CD, Leckman JF, Singer HS. Abnormal dopaminergic neurotransmission in Tourette syndrome: a postmortem analysis. J Neurol Sci. 2007;255(1-2):50-56
20. Lopez PH, Schnaar RL. Determination of glycolipid-protein interaction specificity. Methods Enzymol. 2006;417:205-220
21. Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb from rheumatic carditis recognizes heart valves and lami-nin. J Clin Invest. 2000;106(2):217-224
22. Singer HS, Giuliano JD, Hansen BH, et al. Antibodies against human putamen in children with Tourette syndrome. Neurology. 1998;50(6):1618-1624
23. Lacroix-Desmazes S, Kaveri SV, Mouthon L, et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 1998;216(1-2):117-137
24. Archelos JJ, Hartung HP. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci. 2000;23(7):317-327
25. Martino D, Defazio G, Church AJ, et al. Antineuronal antibody status and phenotype analysis in Tourette's syndrome. Mov Disord. 2007;22(10):1424-1429
26. Dale RC, Church AJ, Candler PM. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology. 2006;66(10):1612; author reply 1612
27. Kawikova I, Leckman JF, Kronig H, et al. Decreased number of regulatory T cells suggests impaired immune tolerance in children with Tourette's syndrome. Biol Psychiatry. 2007;61(3):273-278
28. Zimmerman AW, Jyonouchi H, Comi AM, et al. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol. 2005;33(3):195-201
29. Luo F, Leckman JF, Katsovich L, et al. Prospective longitudinal study of children with tic disorders and/or obsessive- compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics. 2004; 113(6). Available at: www.pediatrics.org/cgi/content/ full/113/6/e578
30. Singer HS, Minzer K. Neurobiology of Tourette syndrome: concepts of neuroanatomical localization and neurochemical abnormalities. Brain Dev. 2003;25(suppl):S70 -S84
31. Berardelli A, Curra A, Fabbrini G, Gilio F, Manfredi M. Pathophysiology of tics and Tourette syndrome. J Neurol. 2003; 250(7):781-787
32. Hoekstra PJ, Anderson GM, Limburg PC, Korf J, Kallenberg CG, Minderaa RB. Neurobiology and neuroimmunology of Tourette's syndrome: an update. Cell Mol Life Sci. 2004;61(7-8): 886-898
33. Singer HS. PANDAS and immunomodulatory therapy. Lancet. 1999;354(9185):1137-1138
34. Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. 1999;354(9185):1153-1158
35. Loiselle CR, Lee O, Moran TH, Singer HS. Striatal microinfu-sion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord. 2004;19(4):390-396